Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options

Author:

Kumar Akash1ORCID,Pramanik Jhilam2,Goyal Nandani3ORCID,Chauhan Dimple4ORCID,Sivamaruthi Bhagavathi Sundaram56ORCID,Prajapati Bhupendra G.7ORCID,Chaiyasut Chaiyavat6ORCID

Affiliation:

1. Department of Food Technology, SRM University, Sonipat 131029, India

2. Department of Food Technology, ITM University, Gwalior 474001, India

3. Department of Skill Agriculture, Shri Vishwakarma Skill University, Gurugram 122003, India

4. School of Bio-Engineering and Food Technology, Shoolini University, Solan 173229, India

5. Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand

6. Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand

7. Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Mehsana 384012, India

Abstract

The gut microbiota is critical for maintaining human health and the immunological system. Several neuroscientific studies have shown the significance of microbiota in developing brain systems. The gut microbiota and the brain are interconnected in a bidirectional relationship, as research on the microbiome–gut–brain axis shows. Significant evidence links anxiety and depression disorders to the community of microbes that live in the gastrointestinal system. Modified diet, fish and omega-3 fatty acid intake, macro- and micro-nutrient intake, prebiotics, probiotics, synbiotics, postbiotics, fecal microbiota transplantation, and 5-HTP regulation may all be utilized to alter the gut microbiota as a treatment approach. There are few preclinical and clinical research studies on the effectiveness and reliability of various therapeutic approaches for depression and anxiety. This article highlights relevant research on the association of gut microbiota with depression and anxiety and the different therapeutic possibilities of gut microbiota modification.

Funder

Chiang Mai University, Chiang Mai, Thailand

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3